Cargando…

Serum and urinary metabolomics and outcomes in cirrhosis

BACKGROUND: Cirrhosis can alter several metabolic pathways. Metabolomics could prognosticate outcomes like hepatic encephalopathy (HE), transplant, hospitalization and death. AIM: Determine changes in serum and urine metabolomics in cirrhotics who develop outcomes. METHODS: Cirrhotic outpatients und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Jasmohan S., Fan, Sili, Thacker, Leroy R., Fagan, Andrew, Gavis, Edith, White, Melanie B., Heuman, Douglas M., Fuchs, Michael, Fiehn, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764675/ https://www.ncbi.nlm.nih.gov/pubmed/31560724 http://dx.doi.org/10.1371/journal.pone.0223061

Ejemplares similares

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2017)

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2015)

Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials
por: Bajaj, Jasmohan S., et al.
Publicado: (2020)

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
por: Ahluwalia, Vishwadeep, et al.
Publicado: (2016)

Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study
por: Acharya, Chathur, et al.
Publicado: (2021)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Gut Microbiota as Biosensors in Patients With Cirrhosis
por: Bajaj, Jasmohan S.
Publicado: (2019)

A specialized HE testing clinic improves rational decision-making for therapy in cirrhosis
por: Nadeem, Mahum, et al.
Publicado: (2023)

Area Deprivation Index and Gut-Brain Axis in Cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2022)

Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Whoop there it is: decoding sleep, cirrhosis, and HE
por: Badal, Bryan D., et al.
Publicado: (2023)

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues
por: Montagnese, Sara, et al.
Publicado: (2019)

Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers
por: Shaw, Jawaid, et al.
Publicado: (2023)

Effect of Increasing Age on Brain Dysfunction in Cirrhosis
por: Liu, Runping, et al.
Publicado: (2018)

Denoising Autoencoder Normalization for Large-Scale Untargeted Metabolomics by Gas Chromatography–Mass Spectrometry
por: Zhang, Ying, et al.
Publicado: (2023)

Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration
por: Wanichthanarak, Kwanjeera, et al.
Publicado: (2017)

Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity
por: Szczerbinski, Lukasz, et al.
Publicado: (2022)

Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
por: Kang, Dae J, et al.
Publicado: (2016)

Sex-associated differences in baseline urinary metabolites of healthy adults
por: Fan, Sili, et al.
Publicado: (2018)

Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
por: Ridlon, Jason M, et al.
Publicado: (2013)

Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice
por: Tu, Lan N., et al.
Publicado: (2017)

Sa1372: TRACKING CIRRHOSIS CARE DURING COVID-19 PANDEMIC
por: Adejumo, Adeyinka C., et al.
Publicado: (2022)

Tu1264: PATIENTS WITH CIRRHOSIS EXPERIENCE HIGHER ICU MORTALITY COMPARED TO NON-CIRRHOTIC PATIENTS WHICH CONTINUED WITH OR WITHOUT COVID-19 DESPITE CONTROLLING FOR ORGAN FAILURE SEVERITY
por: Park, Dan, et al.
Publicado: (2022)

Characterizing patient-reported outcomes in veterans with cirrhosis
por: Rogal, Shari S., et al.
Publicado: (2020)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
por: Barupal, Dinesh Kumar, et al.
Publicado: (2019)

Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis
por: Kind, Tobias, et al.
Publicado: (2016)

Adventures in Developing an App for Covert Hepatic Encephalopathy
por: Bajaj, Jasmohan S
Publicado: (2017)

Short-Term Stability of Serum and Liver Extracts for Untargeted Metabolomics and Lipidomics
por: Hricko, Jiri, et al.
Publicado: (2023)

Combining Genomics, Metabolome Analysis, and Biochemical Modelling to Understand Metabolic Networks
por: Fiehn, Oliver
Publicado: (2001)

Metabolomics Insights Into Pathophysiological Mechanisms of Interstitial Cystitis
por: Fiehn, Oliver, et al.
Publicado: (2014)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

High quality metabolomic data for Chlamydomonas reinhardtii
por: Lee, Do Yup, et al.
Publicado: (2008)

SMetaS: A Sample Metadata Standardizer for Metabolomics
por: Bremer, Parker Ladd, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bc8orcqddpqfb14iguijbrjboq